
Joost Kluiver
dr.
I have a central role in all research projects focusing on the role of noncoding RNAs. My main aim is to understanding how small and long non-coding RNAs contribute to the pathogenesis of B-cell lymphoma. Ongoing studies include MYC-regulated miRNAs and lncRNAs, as well as miRNA-lncRNA interactions and the role of circular RNAs. We apply state-of-the-art methodology including AGO2-RIP, RNA-FISH and gain- and loss-of-function screens using shRNA and CRISPR-Cas technology.
Latest publications
(104)
Activities
(80)
Press/Media
(2)
Prizes
(2)
Datasets
(4)
Supervised work
(17)
Funding received from Lymph&Co for lymphoma research
Grant Awarded by Lymph&Co for the amount of 772.000 euro
Kluiver, Joost (Recipient)
Funding received from Lymph&Co for lymphoma research
Grant Awarded by Lymph&Co for the amount of 772.000 euro
Kluiver, Joost (Recipient)